Clinical Trial Update: Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing 6% Hydroxyethyl Starch solution to an electrolyte solution in patients undergoing elective abdominal surgery to assess safety and effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypovolaemia Due to Acute Blood Loss

Drugs mentioned

• 6% hydroxyethyl starch solution
• electrolyte solution

Snippet

Sponsor: Fresenius Kabi | Conditions: Hypovolaemia Due to Acute Blood Loss | Phase 4 | Status: COMPLETED